Selectis Health (GBCS) Gains from Sales and Divestitures (2020)
Selectis Health's (GBCS) quarterly Gains from Sales and Divestitures came in at $7500.0 in Q4 2020.
Selectis Health (GBCS) Gains from Sales and Divestitures (2020) Analysis & Trends
Selectis Health has disclosed Gains from Sales and Divestitures across 1 years of filings, most recently posting $7500.0 for Q4 2020.
- Gains from Sales and Divestitures for Q4 2020 came in at $7500.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $7500.0 (changed N/A YoY), and the FY2020 annual result was $7500.0, changed N/A from the prior year.
- Gains from Sales and Divestitures came in at $7500.0 for Q4 2020 at Selectis Health.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $7500.0 in Q4 2020 to a low of $7500.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | Selectis Health | - | - | 2.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 7,500.00 |
| Dec 31, 2020 | 7,500.00 |